Aterian (ATER) Proxy filing summary

Executive summary

• Board unanimously approved an $18 million sale of the brand portfolio and a $7 million strategic investment, aiming to return $0.85–$1.14 per share to stockholders and position for future growth.

• Special Meeting of Stockholders scheduled for July 10, 2026, to vote on these transformative transactions.

• Forward-looking statements highlight potential benefits, risks, and uncertainties related to the transactions, including timing, costs, and impact on business relationships.

Voting matters and shareholder proposals

• Stockholders are asked to approve the asset sale to Trademark Global, LLC and the issuance of common stock to David Lazar upon conversion of preferred stock.

• Every vote is emphasized as critical, regardless of share count, to enable the proposed cash distribution and investment.

Board of directors and corporate governance

• Board of Directors unanimously supports both the asset sale and investment transaction.

• Directors and executive officers may be deemed participants in the proxy solicitation, with their interests disclosed in recent SEC filings.